212 related articles for article (PubMed ID: 31373163)
1. Cytokine rs361525, rs1800750, rs1800629, rs1800896, rs1800872, rs1800795, rs1800470, and rs2430561 SNPs in relation with prognostic factors in acute myeloid leukemia.
Bănescu C; Tripon F; Trifa AP; Crauciuc AG; Moldovan VG; Bogliş A; Benedek I; Dima D; Cândea M; Duicu C; Iancu M
Cancer Med; 2019 Sep; 8(12):5492-5506. PubMed ID: 31373163
[TBL] [Abstract][Full Text] [Related]
2. The Associations of IL-6, IFN-γ, TNF-α, IL-10, and TGF-β1 Functional Variants with Acute Myeloid Leukemia in Turkish Patients.
Nursal AF; Pehlivan M; Sahin HH; Pehlivan S
Genet Test Mol Biomarkers; 2016 Sep; 20(9):544-51. PubMed ID: 27486989
[TBL] [Abstract][Full Text] [Related]
3. FLT3-ITD Compared with DNMT3A R882 Mutation Is a More Powerful Independent Inferior Prognostic Factor in Adult Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.
Ardestani MT; Kazemi A; Chahardouli B; Mohammadi S; Nikbakht M; Rostami S; Jalili M; Vaezi M; Alimoghaddam K; Ghavamzadeh A
Turk J Haematol; 2018 Aug; 35(3):158-167. PubMed ID: 29786546
[TBL] [Abstract][Full Text] [Related]
4. DNMT3A (R882) mutation features and prognostic effect in acute myeloid leukemia in Coexistent with NPM1 and FLT3 mutations.
Kumar D; Mehta A; Panigrahi MK; Nath S; Saikia KK
Hematol Oncol Stem Cell Ther; 2018 Jun; 11(2):82-89. PubMed ID: 29079128
[TBL] [Abstract][Full Text] [Related]
5. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in inflammation-related genes and the risk of primary varicose veins in ethnic Russians.
Shadrina A; Voronina E; Smetanina M; Tsepilov Y; Sevost'ianova K; Shevela A; Seliverstov E; Zakharova E; Ilyukhin E; Kirienko A; Zolotukhin I; Filipenko M
Immunol Res; 2018 Feb; 66(1):141-150. PubMed ID: 29247331
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Mutational Status of
Balla B; Tripon F; Lazar E; Bănescu C
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339076
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.
Green CL; Koo KK; Hills RK; Burnett AK; Linch DC; Gale RE
J Clin Oncol; 2010 Jun; 28(16):2739-47. PubMed ID: 20439648
[TBL] [Abstract][Full Text] [Related]
9. DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation.
Ahn JS; Kim HJ; Kim YK; Lee SS; Jung SH; Yang DH; Lee JJ; Kim NY; Choi SH; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim DD
Biol Blood Marrow Transplant; 2016 Jan; 22(1):61-70. PubMed ID: 26234722
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia.
Shamaa S; Laimon N; Aladle DA; Azmy E; Elghannam DM; Salem DA; Taalab MM
Hematology; 2014 Jan; 19(1):22-30. PubMed ID: 23540998
[TBL] [Abstract][Full Text] [Related]
11. Immunorelated gene polymorphisms associated with acute myeloid leukemia.
Liu Q; Hua M; Yan S; Zhang C; Wang R; Yang X; Han F; Hou M; Ma D
Clin Exp Immunol; 2020 Sep; 201(3):266-278. PubMed ID: 32349161
[TBL] [Abstract][Full Text] [Related]
12. Clinical Effect of Combined Mutations in DNMT3A, FLT3-ITD, and NPM1 Among Egyptian Acute Myeloid Leukemia Patients.
El Gammal MM; Ebid GT; Madney YM; Abo-Elazm OM; Kelany AK; Torra OS; Radich JP
Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e281-e290. PubMed ID: 30926392
[TBL] [Abstract][Full Text] [Related]
13. [Effect of FLT3-ITD with DNMT3A R882 double-mutation on the prognosis of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation].
Tang SH; Lu Y; Zhang PS; Liu XH; Du XH; Chen D; Sha KY; Li SY; Cao JJ; Chen LG; Zhuang XX; Pei RZ; Tang XW
Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):552-557. PubMed ID: 30122013
[No Abstract] [Full Text] [Related]
14. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.
Thol F; Damm F; Lüdeking A; Winschel C; Wagner K; Morgan M; Yun H; Göhring G; Schlegelberger B; Hoelzer D; Lübbert M; Kanz L; Fiedler W; Kirchner H; Heil G; Krauter J; Ganser A; Heuser M
J Clin Oncol; 2011 Jul; 29(21):2889-96. PubMed ID: 21670448
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 (1082G/A) Polymorphism is Associated with Susceptibility of Acute Myeloid Leukemia Patients in Sudanese Population.
Sharif OM; Hassan R; Mohammed Basbaeen AA; Mohmed AH; Ibrahim IK
Asian Pac J Cancer Prev; 2019 Jul; 20(7):1939-1943. PubMed ID: 31350948
[TBL] [Abstract][Full Text] [Related]
16. Acute myeloid leukemia patient with
Huang Y; Hu J; Lu T; Luo Y; Shi J; Wu W; Han X; Zheng W; He J; Cai Z; Wei G; Huang H; Sun J
Cancer Manag Res; 2019; 11():4129-4142. PubMed ID: 31190985
[No Abstract] [Full Text] [Related]
17. Effect of Cytokine Genes in the Pathogenesis and on the Clinical Parameters for the Treatment of Multiple Myeloma.
Haydaroglu H; Oguzkan Balcı S; Pehlıvan S; Ozdıllı K; Gundogan E; Okan V; Nursal AF; Pehlıvan M
Immunol Invest; 2017 Jan; 46(1):10-21. PubMed ID: 27611810
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia.
Marková J; Michková P; Burčková K; Březinová J; Michalová K; Dohnalová A; Maaloufová JS; Soukup P; Vítek A; Cetkovský P; Schwarz J
Eur J Haematol; 2012 Feb; 88(2):128-35. PubMed ID: 21967546
[TBL] [Abstract][Full Text] [Related]
19. Prognostic importance of single-nucleotide polymorphisms in IL-6, IL-10, TGF-β1, IFN-γ, and TNF-α genes in chronic phase chronic myeloid leukemia.
Pehlivan M; Sahin HH; Pehlivan S; Ozdilli K; Kaynar L; Oguz FS; Sever T; Yilmaz M; Eser B; Ogret YD; Kis C; Okan V; Cetin M; Carin M
Genet Test Mol Biomarkers; 2014 Jun; 18(6):403-9. PubMed ID: 24819026
[TBL] [Abstract][Full Text] [Related]
20. FLT3-ITD and CEBPA Mutations Predict Prognosis in Acute Myelogenous Leukemia Irrespective of Hematopoietic Stem Cell Transplantation.
Wang H; Chu TT; Han SY; Qi JQ; Tang YQ; Qiu HY; Fu CC; Tang XW; Ruan CG; Wu DP; Han Y
Biol Blood Marrow Transplant; 2019 May; 25(5):941-948. PubMed ID: 30503388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
